The Johns Hopkins Kimmel Cancer Center has finalized a five-year agreement with Allegheny Health Network in Pennsylvania that both medical institutions hope will lead to advancements in cancer treatment and care.
The institutions said they each have strengths in cancer research they hope will complement each other.
"We thought the things we do well and the things they do well were very different and could work together," said Dr. William Nelson, director of the Johns Hopkins Kimmel Cancer Center
Hopkins is a pioneer in cancer genetics, bone marrow transplant medicine and cancer immunotherapy, and it has a strong clinical research program.
Allegheny Health Network has more than 200 clinical trials underway and is home to more than 80 medical, surgical and radiation oncology physician practices. It also has strong bone marrow transplant and cellular therapy programs and the nation's largest radiation oncology network accredited by the American Society for Radiation Oncology and American College of Radiology.
The National Surgical Adjuvant Breast and Bowel Project, a prominent breast and bowel cancer research group, is also based at Allegheny.
Part of the agreement between the two institutions includes creating a fund for cancer research. They will partner in these areas: clinical, research and discovery; quality and safety; and education. Hopkins plans to offer doctor consultation for rare cancer cases and novel therapies and provide Allegheny patients with access to its clinical cancer trials.
"We think that sharing knowledge and expertise like this is how you accelerate cancer treatment and care advances," said David Parda, chair of the Allegheny Health Network Cancer Institute.
The institutions announced in January that they planned to partner.